Literature DB >> 20833648

Mitochondria-specific transgenic overexpression of connexin-43 simulates preconditioning-induced cytoprotection of stem cells.

Gang Lu1, Husnain Kh Haider, Aleksey Porollo, Muhammad Ashraf.   

Abstract

AIMS: We previously reported that preconditioning of stem cells with insulin-like growth factor-1 (IGF-1) translocated connexin-43 (Cx-43) into mitochondria, causing cytoprotection. We posit that these preconditioning effects could be simulated by mitochondria-specific overexpression of Cx-43. METHODS AND
RESULTS: During IGF-1-induced preconditioning of C57black/6 mouse bone marrow stem cell antigen-1(+) (Sca-1(+)) cells, Cx-43 was mainly translocated onto the mitochondrial inner membrane, which was abrogated by an extracellular signal-regulated kinases 1 and 2 (ERK1/2) blocker PD98059. To investigate the role of mitochondrial Cx-43, we successfully designed a vector coding for full-length mouse Cx-43 with a mitochondria-targeting sequence (mito-Cx-43) and cloned into a shuttle vector (pShuttle-IRES-hrGFP-1) for mitochondria-specific overexpression of Cx-43 (mito-Cx-43). Sca-1(+) cells with mito-Cx-43 reduced cytosolic accumulation of cytochrome c, lowered caspase-3 activity, and improved survival during index oxygen-glucose deprivation as determined by terminal deoxynucleotidyl transferase dUTP nick-end labelling and lactate dehydrogenase assays. Computational analysis revealed a B-cell lymphoma-2 (Bcl-2) homology domain-3 (BH3) motif in Cx-43 with a conserved pattern of amino acids consistent with the Bcl-2 family that regulated cytochrome c release. Moreover, computational secondary structure prediction indicated an extended α-helix in this region, a known condition for BH3-driven protein-protein interactions.
CONCLUSION: Cx-43 translocation into mitochondria during preconditioning was ERK1/2-dependent. Expression of mito-Cx-43 simulated the cytoprotective effects of preconditioning in stem cells. Structural features of Cx-43 were shared with the Bcl-2 family as determined by computational analysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833648      PMCID: PMC2952537          DOI: 10.1093/cvr/cvq293

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  30 in total

1.  Proapoptotic activity of ITM2B(s), a BH3-only protein induced upon IL-2-deprivation which interacts with Bcl-2.

Authors:  Aarne Fleischer; Verónica Ayllón; Laure Dumoutier; Jean-Christophe Renauld; Angelita Rebollo
Journal:  Oncogene       Date:  2002-05-09       Impact factor: 9.867

2.  BCL2DB: moving 'helix-bundled' BCL-2 family members to their database.

Authors:  Stanislas Valentin Blaineau; Abdel Aouacheria
Journal:  Apoptosis       Date:  2009-07       Impact factor: 4.677

3.  Effects of substitution of Cx43 by Cx32 on myocardial energy metabolism, tolerance to ischaemia and preconditioning protection.

Authors:  Antonio Rodríguez-Sinovas; Jose A Sánchez; Alejandra González-Loyola; Ignasi Barba; Miriam Morente; Rio Aguilar; Esperanza Agulló; Elisatet Miró-Casas; Neus Esquerda; Marisol Ruiz-Meana; David García-Dorado
Journal:  J Physiol       Date:  2010-02-15       Impact factor: 5.182

4.  No ischemic preconditioning in heterozygous connexin43-deficient mice.

Authors:  Uwe Schwanke; Ina Konietzka; Alexej Duschin; Xiaokui Li; Rainer Schulz; Gerd Heusch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-10       Impact factor: 4.733

5.  Protection afforded by ischemic preconditioning is not mediated by effects on cell-to-cell electrical coupling during myocardial ischemia-reperfusion.

Authors:  Ferran Padilla; David Garcia-Dorado; Antonio Rodríguez-Sinovas; Marisol Ruiz-Meana; Javier Inserte; Jordi Soler-Soler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-07-17       Impact factor: 4.733

6.  Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions.

Authors:  X Li; F R Heinzel; K Boengler; R Schulz; G Heusch
Journal:  J Mol Cell Cardiol       Date:  2004-01       Impact factor: 5.000

Review 7.  The modulatory effects of connexin 43 on cell death/survival beyond cell coupling.

Authors:  Antonio Rodríguez-Sinovas; Alberto Cabestrero; Diego López; Iratxe Torre; Miriam Morente; Arancha Abellán; Elisabet Miró; Marisol Ruiz-Meana; David García-Dorado
Journal:  Prog Biophys Mol Biol       Date:  2007-03-14       Impact factor: 3.667

Review 8.  Structural biology of the Bcl-2 family of proteins.

Authors:  Andrew M Petros; Edward T Olejniczak; Stephen W Fesik
Journal:  Biochim Biophys Acta       Date:  2004-03-01

9.  Phosphorylation of serine 262 in the gap junction protein connexin-43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes.

Authors:  Bradley W Doble; Xitong Dang; Peipei Ping; Robert R Fandrich; Barbara E Nickel; Yan Jin; Peter A Cattini; Elissavet Kardami
Journal:  J Cell Sci       Date:  2004-01-26       Impact factor: 5.285

10.  Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake.

Authors:  Elisabet Miro-Casas; Marisol Ruiz-Meana; Esperanza Agullo; Sabine Stahlhofen; Antonio Rodríguez-Sinovas; Alberto Cabestrero; Inmaculada Jorge; Iratxe Torre; Jesus Vazquez; Kerstin Boengler; Rainer Schulz; Gerd Heusch; David Garcia-Dorado
Journal:  Cardiovasc Res       Date:  2009-05-21       Impact factor: 10.787

View more
  28 in total

1.  Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction.

Authors:  Jingying Hou; Lingyun Wang; Jinghui Hou; Tianzhu Guo; Yue Xing; Shaoxin Zheng; Changqing Zhou; Hui Huang; Huibao Long; Tingting Zhong; Quanhua Wu; Jingfeng Wang; Tong Wang
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

2.  Subcellular preconditioning of stem cells: mito-Cx43 gene targeting is cytoprotective via shift of mitochondrial Bak and Bcl-xL balance.

Authors:  Gang Lu; Shujia Jiang; Muhammad Ashraf; Khawaja Husnain Haider
Journal:  Regen Med       Date:  2012-05       Impact factor: 3.806

Review 3.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

Review 4.  Connexin43 phosphorylation in brain, cardiac, endothelial and epithelial tissues.

Authors:  Lucrecia Márquez-Rosado; Joell L Solan; Clarence A Dunn; Rachael P Norris; Paul D Lampe
Journal:  Biochim Biophys Acta       Date:  2011-07-26

Review 5.  Environmental preconditioning rejuvenates adult stem cells' proliferation and chondrogenic potential.

Authors:  Ming Pei
Journal:  Biomaterials       Date:  2016-11-25       Impact factor: 12.479

Review 6.  Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease.

Authors:  Antonio Rodríguez-Sinovas; Jose Antonio Sánchez; Laura Valls-Lacalle; Marta Consegal; Ignacio Ferreira-González
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

7.  Insulin-like growth factor-1 preconditioning accentuates intrinsic survival mechanism in stem cells to resist ischemic injury by orchestrating protein kinase cα-erk1/2 activation.

Authors:  Gang Lu; Muhammad Ashraf; Khawaja Husnain Haider
Journal:  Antioxid Redox Signal       Date:  2011-10-26       Impact factor: 8.401

Review 8.  Ischemic Conditioning and Atrial Fibrillation: Hope for a NewTherapy?

Authors:  Heiko Schmitt; Bruce T Liang; Christopher Pickett
Journal:  J Atr Fibrillation       Date:  2013-04-06

Review 9.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 10.  Preconditioning strategy in stem cell transplantation therapy.

Authors:  Shan Ping Yu; Zheng Wei; Ling Wei
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.